0001209191-18-020389.txt : 20180316 0001209191-18-020389.hdr.sgml : 20180316 20180316185423 ACCESSION NUMBER: 0001209191-18-020389 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180314 FILED AS OF DATE: 20180316 DATE AS OF CHANGE: 20180316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Popovits Kimberly J CENTRAL INDEX KEY: 0001333482 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 18697048 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-14 0 0001131324 GENOMIC HEALTH INC GHDX 0001333482 Popovits Kimberly J 301 PENOBSCOT DR. REDWOOD CITY CA 94063 1 1 0 0 President and CEO Common Stock 2018-03-09 5 G 0 E 1155 0.00 D 236157 I Held by the Popovits 2010 Trust Common Stock 2018-03-14 4 M 0 5000 17.18 A 241157 I Held by the Popovits 2010 Trust Common Stock 2018-03-14 4 S 0 5000 32.0096 D 236157 I Held by the Popovits 2010 Trust Common Stock 59617 D Common Stock 12298 I Held by Morgan Stanley as Custodian for Benefit of Kimberly Popovits Common Stock 16825 I Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee. Employee Stock Option (right to buy) 17.18 2018-03-14 4 M 0 5000 0.00 D 2020-02-18 Common Stock 0 92900 D These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on June 6, 2017. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. Represents weighted average sale price. Actual sale prices ranged from $31.80 to $32.40. Includes an aggregate of 51,204 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. The option became exercisable as to 25% of the shares on February 18, 2011, and became exercisable as to 1/48th of the shares each full month thereafter. /s/ Jason W. Radford, Attorney-in-fact 2018-03-16